Oncology Success Rate in Mumbai
Access high-quality treatment through JCI & NABH-accredited hospitals, renowned specialists, and end-to-end medical travel support designed around your healing journey.
Plan My Journey
Tell us your condition and budget - our AI matches the right destination, hospital and doctor and visa pathway
Cost calculator
I know my treatment - show me cost from 3 hospitals
5K+ International Patients Treated
40+ Source Countries Served
500+ Accredited Partner Hospitals
98% Patient Satisfaction
80% Average Savings vs USA
10K+ Doctors
NABH, JCI Accredited Hospitals
Free Treatment Plan
Free Consultation with Doctor
5+ Destinations Covered
Written by DivinHeal Editorial Contributor, DivinHeal Medical Team, Healthcare Advisory Team Published on: February 19, 2026
About
Oncology Treatment Success Rate in Mumbai: What Patients Need to Know
Understanding the Oncology success rate in Mumbai is vital for individuals facing cancer treatment decisions. Success rates provide an important perspective on potential outcomes, though they depend significantly on the cancer type, its stage, and the chosen therapeutic approach. Mumbai, as a prominent medical hub, offers a spectrum of advanced oncology services for patients seeking comprehensive care and clear data.
The Oncology survival rate in Mumbai is diligently tracked and compared against national and global benchmarks. Clinical outcomes in the city reflect advanced medical infrastructure and expertise. These aggregated clinical data points help patients understand the general trends. However, it is crucial to remember that individual patient profiles and specific treatment plans invariably influence actual results, leading to variations.
What Success Means in Oncology Treatment
In oncology, "success" encompasses various clinical benchmarks, extending beyond a simple cure. It often refers to complete remission, where all signs of cancer disappear, or significant disease control, halting progression and improving quality of life. Long-term survival, improved functional status, and the prevention of recurrence are also critical indicators of effective treatment, shaping the overall Oncology recovery rate in Mumbai.
Oncology Success Rate Breakdown by Treatment Type
Success rates vary depending on treatment approach and patient factors.
| Treatment Type / Category | Typical Use Case | Success Rate Range (%) | What Success Indicates |
|---|---|---|---|
| Surgical Resection | Early-stage solid tumors | 65%–90% | Complete removal of tumor, disease-free survival |
| Radiation Therapy | Localized tumors, symptom management | 50%–85% | Tumor shrinkage, local control, symptom relief |
| Chemotherapy | Systemic cancers, adjuvant therapy | 40%–75% | Tumor response, remission, slowing disease progression |
| Targeted Therapy | Cancers with specific genetic mutations | 55%–80% | Precise tumor inhibition, prolonged remission |
| Immunotherapy | Advanced cancers, enhancing immune response | 35%–70% | Durable response, long-term disease control |
Stage Wise Oncology Survival Rate in Mumbai and by Age
The stage wise Oncology survival rate in Mumbai and the Oncology survival rate by age in Mumbai are crucial metrics. Outcomes for cancer treatment can vary significantly based on the disease's advancement and the patient's age. This aligns with internationally observed clinical trends, where earlier detection and younger age often correlate with more favorable prognoses across various cancer types globally.
| Age Group / Patient Category | Stage of Cancer | Success Rate Range (%) |
|---|---|---|
| Younger Adults (18-45) | Early Stage (I-II) | 70%–95% |
| Younger Adults (18-45) | Locally Advanced (III) | 50%–75% |
| Middle-Aged Adults (46-65) | Early Stage (I-II) | 60%–85% |
| Middle-Aged Adults (46-65) | Locally Advanced (III) | 40%–60% |
| Older Adults (66+) | Early Stage (I-II) | 50%–70% |
| Older Adults (66+) | Metastatic (IV) | 15%–35% |
Mumbai Oncology Outcomes Compared Globally
Success rates for Oncology treatment in Mumbai are generally comparable with international standards when similar protocols, advanced technology, and rigorous patient selection criteria are meticulously applied. This reflects the city's commitment to adopting global best practices and investing in state-of-the-art medical facilities and highly skilled oncology specialists.
| Country | Treatment Success Rate Range (%) |
|---|---|
| India (Mumbai) | 50%–80% |
| United States | 55%–85% |
| United Kingdom | 50%–80% |
| Germany | 50%–82% |
| Singapore | 55%–83% |
| Thailand | 48%–78% |
| Turkey | 45%–75% |
These success rates are indicative and can vary widely based on specific cancer types, individual patient conditions, and the exact treatment approaches utilized. They are not guaranteed outcomes.
Factors Influencing Oncology Outcomes
- Cancer Type and Stage: Different cancers respond differently, and early detection significantly improves prognosis.
- Patient Age and General Health: Younger, healthier patients often tolerate treatments better and have stronger recovery.
- Presence of Co-morbidities: Pre-existing conditions can impact treatment tolerability and overall outcome.
- Genetic Markers and Tumor Biology: Specific genetic mutations can influence treatment efficacy and disease aggression.
- Treatment Adherence and Response: Consistent follow-through with the prescribed regimen is crucial for optimal results.
- Quality of Care and Technology: Access to advanced diagnostics, skilled specialists, and modern therapies plays a significant role.
Understanding Oncology Outcome Data Sources
- National Cancer Registries: Comprehensive databases collecting incidence, treatment, and survival data for various cancers.
- World Health Organization (WHO) / International Agency for Research on Cancer (IARC): Global reports and statistics on cancer burden and outcomes.
- Peer-Reviewed Medical Studies: Published research from clinical trials and observational studies on treatment efficacy.
- Aggregated Multi-Hospital Outcome Data: Anonymized data from multiple healthcare institutions providing broader insights.
Making Confident Healthcare Choices
Empower yourself with comprehensive, data-driven insights for oncology care. Informed decisions, based on clear understanding of potential outcomes and influencing factors, are paramount for navigating complex medical journeys with confidence and clarity.
Hospitals
NABH & JCI Accredited Hospitals in India,Turkey, Thailand & UAE.
Artemis Hospital
Sector 51, Gurugram, Haryana, India
Lokmanya Hospitals
Not Specified
White Lotus Hospital
766, SFS 3145, SFS Road, 7th Sector, HSR Layout, Bengaluru, Karnataka 560102, India
Institute of Brain and Spine (IBS Hospital)
Not Specified
Meet Our Medical Specialists
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
Sr. Consultant - Urology & Kidney Transplant Program (Unit I)
Dr. Abhinandan Mukhopadhyay
MBBS, MD
India
How DivinHeal Helps
We simplify your medical journey by providing comprehensive support and access to world-class healthcare.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Accredited Hospital Network
Access to JCI & NABH certified healthcare facilities.
Complete Travel Coordination
Hassle-free visa, stay, and local transport assistance.
24/7 Personal Care
Dedicated patient advisors supporting you at every step.
Journey Guidance
Full guidance from start to end of the patient treatment journey.
Expert Specialist Matching
Connecting you with the world's top-rated medical experts.
Everything you
need to know today
Browse through these common inquiries to better understand our patient-focused medical platform.
Yes, we work with a variety of insurance providers. Contact our team to verify your coverage.
Yes, we provide secure online consultations with experienced specialists.
Our care coordinators help match you with the most suitable specialist.
Absolutely. Your medical information is protected according to healthcare privacy standards.
Look at six things: accreditation (JCI or NABH), specialty depth, doctor credentials and experience, procedure-specific success rates, international patient support, and technology. DivinHeal's AI-driven matching evaluates every hospital in our accredited partner network on these dimensions and shortlists the best-fit options for your condition, budget, and country.
JCI (Joint Commission International) is the US-based global gold standard for hospital quality, recognised worldwide. NABH is India's national accreditation — accredited by ISQua, the same body that accredits JCI. Both signal independently verified safety and quality. Most of India's leading hospitals hold both.
Yes. All three welcome international patients through structured medical visa programs. India is the most established, treating patients from Africa, the Middle East, and South Asia at 60–80% lower cost. Thailand leads in cosmetic and dental care. The UAE is emerging in oncology and reproductive medicine.
Most patients save 50–80% on treatment costs. Heart bypass costs US $7,000–9,000 in India compared to $70,000–150,000 in the US. IVF costs $3,000–4,500 compared to $12,000–20,000 in the UK. Even after flights, visa, and accommodation, total savings remain 60–70%.
DivinHeal manages your entire non-medical journey: visa invitation letters, medical visa guidance, doctor appointments, teleconsultations, airport pickup, hospital-vetted accommodation for you and your attendant, language interpreters, local transport, cuisine preferences, and post-treatment follow-up — one dedicated coordinator from first enquiry to final follow-up.
You need a valid passport (6+ months validity), a medical visa (M-Visa for India — DivinHeal provides the hospital invitation letter), return flight tickets, recent medical reports and a doctor's referral, current prescription list, and proof of financial means. Any accompanying attendant needs their own passport and MX-Visa.
Still have more questions?
Book a call with our friendly team to learn how DivineHeal simplifies your healthcare journey.